This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 16:40, 8 January 2011 (Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 16:40, 8 January 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to watched fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Misplaced Pages)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Amlodipine/benazepril" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
Combination of | |
---|---|
Amlodipine | Calcium channel blocker |
Benazepril | ACE inhibitor |
Clinical data | |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril). This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
See also
References
External links
- Novartis: Lotrel official website
- Drugs.com: Lotrel
- RxList.com: Lotrel
Antihypertensive drugs acting on the renin–angiotensin system (C09) | |
---|---|
ACE inhibitors ("-pril") |
|
AIIRAs ("-sartan") |
|
Renin inhibitors ("-kiren") | |
Dual ACE/NEP inhibitors | |
Neprilysin inhibitors | |
Other | |
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |